14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 22 days ( 0 % )
Last Price $2.40 0 %
High/ Low $2.40 - $2.40 0%
Chg 7 Days N/A $2.40 $2.40
Chg 30 Days N/A $2.40 $2.40
Chg 12 mos 18.81 % $2.02 $2.40
Trend - 3 mos -24.10 % Width: 163.60 %
Trend - 12 mos 60.66 % Width: 82.50 %
Pred. range - 3 mos $1.05 - $2.77 -56.26 % - 15.29 %
Pred. range - 12 mos $4.12 - $7.51 71.49 % - 212.97 %
Short MA avg 3 mos Sell Aug 27, 2024 - 27 days
Long MA avg 3 mos Sell Aug 28, 2024 - 26 days
Short/Long MA avg 3 mos Sell Sep 03, 2024 - 23 days
Short MA avg 12 mos Sell Aug 28, 2024 - 26 days
Long MA avg 12 mos Sell Aug 28, 2024 - 26 days
Short/Long MA avg 12 mos Sell Aug 07, 2024 - 41 days
Pivot Short Buy Aug 30, 2024 - 24 days
Bollinger Sell Nov 30, -0001 - N/A days
MACD Buy No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!
ABOUT ARCA BIOPHARMA
ARCA biopharma
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. Its lead product candidates are Recombinant Nematode Anticoagulant Protein c2 (rNAPc2) (AB201), which is in Phase IIb clinical trial for the treatment for COVID-19; and Gencaro (bucindolol hydrochloride), a pharmacogenetically-targeted beta-adrenergic receptor antagonist that has completed Phase...
GOLDEN STAR
Ticker Change Signal Date
WM
$207.93
0.558% Oct 01
VET
$9.77
7.06% Sep 30
FSK
$19.73
1.57% Sep 30
XOM
$115.82
5.84% Sep 27
HES
$133.61
5.43% Sep 27

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE